The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Clinical Diagnostics PCR Market Research Report 2025
Synopsis
Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials.
The global Clinical Diagnostics PCR market was valued at US$ 8615 million in 2023 and is anticipated to reach US$ 13320 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
A significant driver in the clinical diagnostics PCR (Polymerase Chain Reaction) market is the increasing demand for accurate and rapid molecular diagnostic tests, particularly in infectious disease management and genetic testing. PCR technology offers high sensitivity and specificity, making it indispensable for disease detection and monitoring. However, a notable challenge in this market is the need for advanced assay development and standardization. Ensuring the reliability and reproducibility of PCR-based tests across different laboratories and diagnostic platforms poses a challenge. Manufacturers and healthcare professionals must collaborate to address these challenges, enabling consistent and accurate PCR-based clinical diagnostics to meet the evolving demands of modern healthcare.
This report aims to provide a comprehensive presentation of the global market for Clinical Diagnostics PCR, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Diagnostics PCR.
Report Scope
The Clinical Diagnostics PCR market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Diagnostics PCR market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Diagnostics PCR companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Agilent Technologies
Qiagen
Thermo Fisher Scientific
DAAN Gene
Hologic
Diagenode
Bio-Rad
Takara Bio
Meridian Bioscience
Toyobo
SSI Diagnostica
Genekam
Segment by Type
Infectious Disease
Cancer
Cardiovascular
Genetic
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Diagnostics PCR companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials.
The global Clinical Diagnostics PCR market was valued at US$ 8615 million in 2023 and is anticipated to reach US$ 13320 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
A significant driver in the clinical diagnostics PCR (Polymerase Chain Reaction) market is the increasing demand for accurate and rapid molecular diagnostic tests, particularly in infectious disease management and genetic testing. PCR technology offers high sensitivity and specificity, making it indispensable for disease detection and monitoring. However, a notable challenge in this market is the need for advanced assay development and standardization. Ensuring the reliability and reproducibility of PCR-based tests across different laboratories and diagnostic platforms poses a challenge. Manufacturers and healthcare professionals must collaborate to address these challenges, enabling consistent and accurate PCR-based clinical diagnostics to meet the evolving demands of modern healthcare.
This report aims to provide a comprehensive presentation of the global market for Clinical Diagnostics PCR, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Diagnostics PCR.
Report Scope
The Clinical Diagnostics PCR market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Diagnostics PCR market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Diagnostics PCR companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Agilent Technologies
Qiagen
Thermo Fisher Scientific
DAAN Gene
Hologic
Diagenode
Bio-Rad
Takara Bio
Meridian Bioscience
Toyobo
SSI Diagnostica
Genekam
Segment by Type
Infectious Disease
Cancer
Cardiovascular
Genetic
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Diagnostics PCR companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Diagnostics PCR Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Infectious Disease
1.2.3 Cancer
1.2.4 Cardiovascular
1.2.5 Genetic
1.2.6 Others
1.3 Market by Application
1.3.1 Global Clinical Diagnostics PCR Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Diagnostics PCR Market Perspective (2019-2030)
2.2 Clinical Diagnostics PCR Growth Trends by Region
2.2.1 Global Clinical Diagnostics PCR Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clinical Diagnostics PCR Historic Market Size by Region (2019-2024)
2.2.3 Clinical Diagnostics PCR Forecasted Market Size by Region (2025-2030)
2.3 Clinical Diagnostics PCR Market Dynamics
2.3.1 Clinical Diagnostics PCR Industry Trends
2.3.2 Clinical Diagnostics PCR Market Drivers
2.3.3 Clinical Diagnostics PCR Market Challenges
2.3.4 Clinical Diagnostics PCR Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Diagnostics PCR Players by Revenue
3.1.1 Global Top Clinical Diagnostics PCR Players by Revenue (2019-2024)
3.1.2 Global Clinical Diagnostics PCR Revenue Market Share by Players (2019-2024)
3.2 Global Clinical Diagnostics PCR Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Diagnostics PCR Revenue
3.4 Global Clinical Diagnostics PCR Market Concentration Ratio
3.4.1 Global Clinical Diagnostics PCR Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Diagnostics PCR Revenue in 2023
3.5 Clinical Diagnostics PCR Key Players Head office and Area Served
3.6 Key Players Clinical Diagnostics PCR Product Solution and Service
3.7 Date of Enter into Clinical Diagnostics PCR Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Diagnostics PCR Breakdown Data by Type
4.1 Global Clinical Diagnostics PCR Historic Market Size by Type (2019-2024)
4.2 Global Clinical Diagnostics PCR Forecasted Market Size by Type (2025-2030)
5 Clinical Diagnostics PCR Breakdown Data by Application
5.1 Global Clinical Diagnostics PCR Historic Market Size by Application (2019-2024)
5.2 Global Clinical Diagnostics PCR Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Clinical Diagnostics PCR Market Size (2019-2030)
6.2 North America Clinical Diagnostics PCR Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clinical Diagnostics PCR Market Size by Country (2019-2024)
6.4 North America Clinical Diagnostics PCR Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Diagnostics PCR Market Size (2019-2030)
7.2 Europe Clinical Diagnostics PCR Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clinical Diagnostics PCR Market Size by Country (2019-2024)
7.4 Europe Clinical Diagnostics PCR Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Diagnostics PCR Market Size (2019-2030)
8.2 Asia-Pacific Clinical Diagnostics PCR Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clinical Diagnostics PCR Market Size by Region (2019-2024)
8.4 Asia-Pacific Clinical Diagnostics PCR Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Diagnostics PCR Market Size (2019-2030)
9.2 Latin America Clinical Diagnostics PCR Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clinical Diagnostics PCR Market Size by Country (2019-2024)
9.4 Latin America Clinical Diagnostics PCR Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Diagnostics PCR Market Size (2019-2030)
10.2 Middle East & Africa Clinical Diagnostics PCR Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clinical Diagnostics PCR Market Size by Country (2019-2024)
10.4 Middle East & Africa Clinical Diagnostics PCR Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Clinical Diagnostics PCR Introduction
11.1.4 Roche Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Clinical Diagnostics PCR Introduction
11.2.4 Abbott Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Clinical Diagnostics PCR Introduction
11.3.4 Agilent Technologies Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.3.5 Agilent Technologies Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Detail
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Clinical Diagnostics PCR Introduction
11.4.4 Qiagen Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.4.5 Qiagen Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Clinical Diagnostics PCR Introduction
11.5.4 Thermo Fisher Scientific Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 DAAN Gene
11.6.1 DAAN Gene Company Detail
11.6.2 DAAN Gene Business Overview
11.6.3 DAAN Gene Clinical Diagnostics PCR Introduction
11.6.4 DAAN Gene Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.6.5 DAAN Gene Recent Development
11.7 Hologic
11.7.1 Hologic Company Detail
11.7.2 Hologic Business Overview
11.7.3 Hologic Clinical Diagnostics PCR Introduction
11.7.4 Hologic Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.7.5 Hologic Recent Development
11.8 Diagenode
11.8.1 Diagenode Company Detail
11.8.2 Diagenode Business Overview
11.8.3 Diagenode Clinical Diagnostics PCR Introduction
11.8.4 Diagenode Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.8.5 Diagenode Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Detail
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Clinical Diagnostics PCR Introduction
11.9.4 Bio-Rad Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.9.5 Bio-Rad Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Detail
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Clinical Diagnostics PCR Introduction
11.10.4 Takara Bio Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.10.5 Takara Bio Recent Development
11.11 Meridian Bioscience
11.11.1 Meridian Bioscience Company Detail
11.11.2 Meridian Bioscience Business Overview
11.11.3 Meridian Bioscience Clinical Diagnostics PCR Introduction
11.11.4 Meridian Bioscience Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.11.5 Meridian Bioscience Recent Development
11.12 Toyobo
11.12.1 Toyobo Company Detail
11.12.2 Toyobo Business Overview
11.12.3 Toyobo Clinical Diagnostics PCR Introduction
11.12.4 Toyobo Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.12.5 Toyobo Recent Development
11.13 SSI Diagnostica
11.13.1 SSI Diagnostica Company Detail
11.13.2 SSI Diagnostica Business Overview
11.13.3 SSI Diagnostica Clinical Diagnostics PCR Introduction
11.13.4 SSI Diagnostica Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.13.5 SSI Diagnostica Recent Development
11.14 Genekam
11.14.1 Genekam Company Detail
11.14.2 Genekam Business Overview
11.14.3 Genekam Clinical Diagnostics PCR Introduction
11.14.4 Genekam Revenue in Clinical Diagnostics PCR Business (2019-2024)
11.14.5 Genekam Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
